Skip to main content

Table 1 Demography of patient cohort

From: Incidence and survival of epithelial ovarian, fallopian tube, peritoneal, and undesignated abdominal/pelvic cancers in Sweden 1960–2014: A population-based cohort study

 

1960–1969

1970–1979

1980–1989

1990–1999

2000–2009

2010–2014

Total

Age median, yrs (range)

59 (18–94)

62 (18–97)

65 (18–100)

66 (18–98)

66 (18–98)

67 (18–100)

64 (18–100)

Age groups, yrs

n (%)

n (%)

n (%)

n (%)

n (%)

n (%)

n (%)

18–44

806 (13)

845 (10)

842 (9.1)

690 (7.5)

514 (5.7)

204 (4.6)

3901 (8)

45–54

1543 (25)

1668 (20)

1345 (15)

1622 (18)

1206 (13)

531 (12)

7915 (17)

55–64

1836 (30)

2239 (27)

2366 (26)

2004 (22)

2364 (26)

1020 (23)

11,829 (26)

65–74

1454 (23)

2152 (26)

2725 (30)

2609 (28)

2370 (26)

1460 (33)

12,770 (28)

75+

561 (9.1)

1341 (16)

1903 (21)

2232 (24)

2633 (29)

1265 (28)

9635 (21)

Total

6200 (100.0)

8245 (100.0)

9181 (100.0)

9157 (100.0)

9087 (100.0)

4480 (100.0)

46,350 (100)

 

1960–1969

1970–1979

1980–1989

1990–1999

2000–2009

2010–2014

Total

Site

n (%)

n (%)

n (%)

n (%)

n (%)

n (%)

n (%)

Ovarian

5560 (90)

6990 (85)

7544 (82)

7598 (83)

6899 (76)

2947 (66)

37,538 (81)

Fallopian

98 (1.6)

99 (1.2)

148 (1.6)

293 (3.2)

368 (4.1)

311 (6.9)

1317 (2.8)

Peritoneal

0 (0)

0 (0)

3 (0.03)

16 (0.17)

236 (2.6)

292 (6.5)

547 (1.2)

Undesignated

542 (8.7)

1156 (14)

1486 (16)

1250 (14)

1584 (17)

930 (21)

6948 (15)

Total

6200 (100.0)

8245 (100.0)

9181 (100.0)

9157 (100.0)

9087 (100.0)

4480 (100.0)

46,350 (100)

Morphology

  

1995–1999

2000–2004

2005–2009

2010–2014

Total

   

n (%)

n (%)

n (%)

n (%)

n (%)

Serous

  

1720 (38)

1848 (39)

2144 (49)

2546 (57)

8258 (46)

Mucinous

  

455 (10)

379 (8.1)

299 (6.8)

304 (6,8)

1437 (8.0)

Endometrioid

  

535 (12)

506 (11)

393 9.0)

346 (7.7)

1780 (9.8)

Clear cell

  

192 (4.2)

164 (3.5)

180 (4.1)

197 (4.4)

733 (4.1)

Undifferentiateda

  

1495 (33)

1656 (35)

1234 (28)

936 (21)

5321 (29)

Otherb

  

136 (3.0)

147 (3.1)

128 (2.9)

146 (3.2)

557 (3.1)

N.a.

  

9 (0.2)

4 (0.1)

5 (0.1)

5 (0.1)

23 (0.1)

Total

  

4542 (100.0)

4704 (100.0)

4383 (100.0)

4480 (100.0)

18,109 (100)

FIGO stage

    

2005–2009

2010–2014

Total

Ovarian cancerc

    

n (%)

n (%)

n (%)

I

    

719 (16)

774 (17)

1493 (17)

II

    

296 (6.8)

313 (7)

609 (6.9)

III

    

1619 (37)

1826 (41)

3445 (39)

IV

    

507 (12)

709 (16)

1216 (14)

N.a.

    

1242 (28)

858 (19)

2100 [24]

Total

    

4383 (100.0)

4480 (100.0)

8863 (100)

  1. aNeoplasm – malignant, carcinoma NOS, carcinoma – undifferentiated NOS, carcinoma – anaplastic NOS, adenocarcinoma NOS
  2. bOther morphologies: Squamous cell carcinoma NOS (81), Lymphoepithelial carcinoma (1), Transitional cell carcinoma NOS (14), Basaloid carcinoma (1), Carcinoid tumor NOS (78), Atypical carcinoid tumor (1), Signet ring cell carcinoma (17) Adenosarcoma (1), Mullerian mixed tumor (152), Mesodermal mixed tumor (39), Carcinosarcoma NOS (141), Mesonephroma malignant (31)
  3. cStage distribution for ovarian cancer only, due to low case load or lacking FIGO stage definitions for other tumor sites
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us